Free Trial
OTCMKTS:TSNDF

TerrAscend 8/10/2023 Earnings Report

TerrAscend logo
$0.42 +0.03 (+6.44%)
As of 05/20/2025 03:59 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.04
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$72.12 million
Expected Revenue
$71.54 million
Beat/Miss
Beat by +$580.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
TerrAscend Closes on Ohio Dispensary Acquisition
3 TSX Penny Stocks With Market Caps Over CA$20M
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat